BIO-TECHNE Corp 4
4 · BIO-TECHNE Corp · Filed May 31, 2017
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Dinarello Charles A
Director
Transactions
- Sale
Common Stock
2017-05-31$111.37/sh−5,000$556,862→ 7,473 total - Exercise/Conversion
Common Stock
2017-05-26$66.59/sh+5,000$332,950→ 12,473 total - Exercise/Conversion
Stock Options (Right to buy)
2017-05-26−5,000→ 0 totalExercise: $66.59From: 2007-10-25Exp: 2017-10-24→ Common Stock (5,000 underlying)
Holdings
- 4,000
Stock Option (right to buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $70.35From: 2011-10-27Exp: 2021-10-26→ Common Stock (5,000 underlying) - 3,985
Stock Options (Right to buy)
Exercise: $101.19Exp: 2026-10-26→ Common Stock (3,985 underlying) - 5,000
Stock Option (right to buy)
Exercise: $65.47From: 2008-10-23Exp: 2018-10-22→ Common Stock (5,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $63.03From: 2009-10-29Exp: 2019-10-28→ Common Stock (5,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $61.46From: 2010-10-28Exp: 2020-10-27→ Common Stock (5,000 underlying) - 4,000
Stock Option (right to buy)
Exercise: $87.39From: 2013-10-31Exp: 2023-10-30→ Common Stock (4,000 underlying) - 4,260
Stock Option (right to buy)
Exercise: $87.34From: 2015-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying) - 5,000
Stock Option (right to buy)
Exercise: $66.90From: 2012-10-25Exp: 2022-10-24→ CommonS tock (5,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.3699 to $111.3790, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option vests on the earlier of the one year anniversary of the grant date (10/27/2017) or the date of Bio-Techne 2017 annual meeting of shareholders.